Company Filing History:
Years Active: 2025
Title: Claude Nicolas Holenstein: Innovator in Tissue Engineering
Introduction
Claude Nicolas Holenstein is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of tissue engineering, particularly through his innovative work on tissue culture vessels. With a focus on enhancing the preparation of compressed hydrogel skin grafts, Holenstein's creations have the potential to impact medical procedures related to skin transplantation and repair.
Latest Patents
Holenstein holds a patent titled "Tissue culture vessel for preparation of compressed hydrogel skin grafts and related methods and systems." This patent outlines a sophisticated tissue culture vessel that includes a graft support tray and a box with a lid and base designed to securely retain the tray. The innovative design allows the tray to function in two operational states: one where the floor of the tray is slightly raised relative to the base, and another where it descends to make contact with the base. This versatility enhances the practicality of hydrogel skin graft preparation.
Career Highlights
Currently, Claude Nicolas Holenstein is affiliated with Cutiss AG, a company dedicated to advancing skin graft technology and tissue engineering solutions. His work emphasizes research and practical applications that improve patient outcomes in skin treatments. As an inventor, he continues to push the boundaries of medical innovation with a focus on creating effective and reliable solutions for skin graft procedures.
Collaborations
During his tenure at Cutiss AG, Holenstein has collaborated with several talented professionals, including Vincent Ronfard and Anna-Lena Dittrich. These collaborations are crucial for fostering an environment of innovation, where diverse ideas converge to enhance the development and implementation of advanced tissue culture techniques.
Conclusion
Claude Nicolas Holenstein stands out as a notable inventor in the field of tissue engineering. His patented tissue culture vessel represents a significant achievement in medical innovation, with the potential to improve skin graft procedures significantly. With his ongoing work at Cutiss AG and collaborations with skilled colleagues, Holenstein continues to pave the way for advancements that can lead to better healthcare solutions.